TY  - GEN
AU  - Buontempo,Francesca
AU  - Orsini,Ester
AU  - Lonetti,Annalisa
AU  - Cappellini,Alessandra
AU  - Chiarini,Francesca
AU  - Evangelisti,Camilla
AU  - Evangelisti,Cecilia
AU  - Melchionda,Fraia
AU  - Pession,Andrea
AU  - Bertaina,Alice
AU  - Locatelli,Franco
AU  - Bertacchini,Jessika
AU  - Neri,Luca Maria
AU  - McCubrey,James A
AU  - Martelli,Alberto Maria
TI  - Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival ER chaperone BIP/Grp78 and turning on the pro-apoptotic NF-κB
SN  - 1949-2553
PY  - 2016///1213
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Apoptosis
KW  - drug effects
KW  - Blotting, Western
KW  - Bortezomib
KW  - Casein Kinase II
KW  - antagonists & inhibitors
KW  - Cell Line, Tumor
KW  - Cell Survival
KW  - Drug Synergism
KW  - Endoplasmic Reticulum Chaperone BiP
KW  - Endoplasmic Reticulum Stress
KW  - Heat-Shock Proteins
KW  - metabolism
KW  - Humans
KW  - Jurkat Cells
KW  - Microscopy, Fluorescence
KW  - Naphthyridines
KW  - Neoplastic Stem Cells
KW  - Phenazines
KW  - Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
KW  - blood
KW  - Precursor Cell Lymphoblastic Leukemia-Lymphoma
KW  - Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
KW  - Transcription Factor RelA
KW  - Unfolded Protein Response
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.18632/oncotarget.6361
ER  -